Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/jRCT1080224764
jRCT1080224764CompletedPhase 2

A clinical study of CL2020 in patients with spinal cord injury

Life Science Institute Inc.1 site10 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
10
Locations
1
Primary Endpoint
-
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Intervention Model
Open Label, Non-randomized
Primary Purpose
Treatment Purpose

Eligibility Criteria

Ages
16age old over to 74age old under (—)
Sex
All

Inclusion Criteria

  • •Patients with cervical spinal cord injury within 2weeks of injury
  • •Severity of modified Frankel classification grade B1 or B2
  • •Patients with Neurological level of injury between C4 and C7

Exclusion Criteria

  • •Patients with any existing or previous malignant tumor
  • •Female patients who are or may be pregnant or who are breastfeeding

Outcomes

Primary Outcomes

-

efficacy efficacy after infusion of CL2020

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Life Science Institute Inc.

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 2
A clinical study of CL2020 in patients with spinal cord injuryspinal cord injury
JPRN-jRCT1080224764ife Science Institute Inc.10
Completed
Phase 3
A confirmatory study of CL2020 in patients with ST-elevation myocardial infarction
jRCT1080224979Life Science Institute Inc.83
Completed
Not Applicable
Spinal system multicenter RCT study for Idiopathic ScoliosisIdiopathic Scoliosis
JPRN-UMIN000008838Stryker Japan80
Completed
Phase 2
Spinal manipulation in the treatment of patients with lumbar disc herniation who had sacroiliac joint hypomobility
IRCT2017011924149N33Vice Chancellery for Research Affairs, Shiraz University of Medical Sciences20
Completed
Not Applicable
Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection (Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection)
jRCT2043210005Life Science Institute, Inc.43